XTX Topco Ltd - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 90 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$40,210
-85.5%
15,289
-80.5%
0.01%
-86.0%
Q2 2023$276,929
+9.8%
78,450
-3.9%
0.05%
-5.7%
Q1 2023$252,203
-36.8%
81,619
-13.5%
0.05%
-37.6%
Q4 2022$399,122
+504.7%
94,355
+236.3%
0.08%
+431.2%
Q3 2022$66,000
-35.9%
28,056
-22.3%
0.02%
-61.9%
Q2 2022$103,000
-41.5%
36,130
-41.0%
0.04%
-45.5%
Q1 2022$176,000
+91.3%
61,218
+102.0%
0.08%
+48.1%
Q4 2021$92,000
-36.1%
30,308
+93.0%
0.05%
+6.1%
Q2 2021$144,00015,7050.05%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
HARVARD MANAGEMENT CO INC 600,000$45,216,0003.56%
Avalon Global Asset Management LLC 32,900$2,479,0001.79%
CORNERSTONE CAPITAL MANAGEMENT LLC 495,145$37,314,0001.58%
BB BIOTECH AG 521,991$39,337,0001.25%
WEATHERBIE CAPITAL, LLC 137,041$10,327,0001.20%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$428,527,0001.19%
TOBAM 318,384$23,994,0000.94%
Orbimed Advisors 1,195,500$90,093,0000.91%
Capital International Sarl 109,405$8,245,0000.74%
CAPITAL INTERNATIONAL LTD /CA/ 145,697$10,980,0000.73%
View complete list of PUMA BIOTECHNOLOGY INC shareholders